Considered “eat me signals”, Hsp70 and calreticulin can interact with a variety of APC surface receptors, such as CD91 and CD40, to promote the cross-presentation of antigens on MHC class I molecules, thus triggering a tumor-specific CD8+ T-cell response (86–88). The gene discussed is CALR; the disease is neoplasm.